A Two-Part, Randomized, Open-label, Multicenter, Phase 2a/2b Study of the Efficacy, Safety, and Pharmacokinetics of KRT-232 Compared to Ruxolitinib in Patients with Phlebotomy-Dependent Polycythemia Vera (KRT-232-102)

  • Perkins, Andrew (Primary Chief Investigator (PCI))
  • Burbury, Kate L (Chief Investigator (CI))
  • Kennedy, Nola (Project Manager)

Project: Research

StatusActive
Effective start/end date20/01/20 → 31/12/25
View all
View less

Keywords

  • Malignant Haematology
  • Polycythemia Vera
  • Clinical trial